NEW MILTON, UK--(BUSINESS WIRE)--Genetix, a leading developer of technologies for automated, high throughput cell identification and selection for the pharmaceutical, biotechnology and clinical diagnostics industries, today announced that the Monash Antibody Technologies Facility (MATF) at Monash University, in Australia has selected ClonePix FL technology to speed up the identification and isolation of thousands of cell lines for monoclonal antibody (MAb) production.
